Metfor XR Indications/Uses

500 mg: Risk reduction or delayed onset of type 2 diabetes mellitus in adult, overweight patients with IGT* and/or IFG*, and/or increased HbA1C who are: with high risk for developing overt type 2 diabetes mellitus and still improving towards type 2 diabetes mellitus despite exertion of intensive change in lifestyle for 3 to 6 months.
Treatment with Metformin Hydrochloride Extended Release Tablets should be based on a risk score with appropriate measures to control glycemic activity which also includes evidence of high cardiovascular risk.
Other than medical reason that the patient is unable to do lifestyle modifications, it should be continued when metformin is initiated.
*IGT: Impaired Glucose Tolerance; IFG: Impaired Fasting Glucose.
Treatment of type 2 diabetes mellitus in adults, particularly in obese patients, when food and exercise therapy alone do not achieve optimal glycemic control. Metfor XR can be used alone or in combination with other oral diabetes medications or insulin.
750 mg: Metformin hydrochloride is used for the management of type 2 diabetes mellitus as monotherapy, and as an adjunct to diet and exercise to improve glycemic control.